Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases ; volume:12 ; number:7 ; day:6 ; month:7 ; year:2022 ; pages:1-4 ; date:7.2022
Blood cancer journal ; 12, Heft 7 (6.7.2022), 1-4, 7.2022
- Creator
-
Abdelmagid, Maymona G.
Litzow, Mark R.
McCullough, Kristen B.
Gangat, Naseema
Pardanani, Animesh
Murthy, Hemant S.
Foran, James M.
Ketterling, Rhett P.
Viswanatha, David
Begna, Kebede H.
Tefferi, Ayalew
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-022-00696-4
- URN
-
urn:nbn:de:101:1-2022082520310886262027
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abdelmagid, Maymona G.
- Litzow, Mark R.
- McCullough, Kristen B.
- Gangat, Naseema
- Pardanani, Animesh
- Murthy, Hemant S.
- Foran, James M.
- Ketterling, Rhett P.
- Viswanatha, David
- Begna, Kebede H.
- Tefferi, Ayalew
- SpringerLink (Online service)
Other Objects (12)
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
MicroRNA und mRNA Expressionsmuster bei BCR-ABL1-positiver CML und JAK2 p. V617F-positiven chronisch-myeloproliferativen Erkrankungen
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
MicroRNA und mRNA Expressionsmuster bei BCR-ABL1-positiver CML und JAK2 p. V617F-positiven chronisch-myeloproliferativen Erkrankungen
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
MicroRNA und mRNA Expressionsmuster bei BCR-ABL1-positiver CML und JAK2 p. V617F-positiven chronisch-myeloproliferativen Erkrankungen
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1